Revance Therapeutics Inc. buy Saftman
Start price
24.01.23
/
50%
€30.40
Target price
24.01.24
-
Performance (%)
-82.57%
End price
25.01.24
€5.30
Summary
This prediction ended on 25.01.24 with a price of €5.30. Massive losses of -82.57% were the result for the BUY prediction by Saftman. Saftman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Revance Therapeutics Inc. | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Saftman for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Saftman hat das Wertpapier Revance Therapeutics Inc. in seinem Wikifolio Langfristige Aufwärtstrends gekauft.
In the thread Trading Revance Therapeutics Inc.
Die von Saftman gewählte maximale Laufzeit wurde überschritten